| Financial Year |
March 31 2023 |
| Monetary Funds |
924,530,245.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,000,000.00 |
| Accounts Receivable |
45,938,119.59 |
| Advances to Suppliers |
100,191,759.88 |
| Other Receivables |
28,077,754.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
14,908,077.89 |
| Inventories |
960,018,312.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
140,185,766.91 |
| Total Current Assets |
2,220,501,260.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,140,033,041.38 |
| Investment Properties |
-- |
| Fixed Assetes |
2,075,842,164.11 |
| Under-construction Projects |
54,945,755.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
87,959,758.49 |
| R&D expenses |
-- |
| Goodwill |
31,789,710.81 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
98,315,447.84 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,823,781,501.55 |
| Total Assets |
8,044,282,762.31 |
| Short-Term Loans |
856,473,358.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
417,000,000.00 |
| Accounts Payable |
300,742,958.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,618,384.01 |
| Taxes Payable |
11,046,038.12 |
| Interest Payable |
-- |
| Dividend Payable |
414,770.29 |
| Other payables |
251,615,443.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,987,822.46 |
| Other Current Liabilities |
5,766,290.28 |
| Sub-Total of Current Liabilities |
1,950,606,374.94 |
| Long-term Loans |
730,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,250,841.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
773,587,845.35 |
| Total Liabilities |
2,724,194,220.29 |
| Paid-In Capital(Or Share Stock) |
1,192,199,394.00 |
| Capital Surplus |
1,651,352,956.47 |
| Surplus Reserve |
474,137,640.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,062,292,880.42 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,320,088,542.02 |
| Owner's Equity（Stockholder's Equity） |
5,320,088,542.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,044,282,762.31 |
